SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) - CELLDEX THERAPEUTICS INC NEW ownership

Back to all holdings Add to watchlist

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 137 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2014. The put-call ratio across all filers is 1.85 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2014$27,000
-25.0%
1,5000.0%0.01%
-25.0%
Q4 2013$36,000
-32.1%
1,5000.0%0.01%
-40.0%
Q3 2013$53,000
+130.4%
1,5000.0%0.02%
+150.0%
Q2 2013$23,000–1,500–0.01%–
 Download
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q2 2014
NameSharesValueWeighting ↓
Byrne Asset Management LLC 86$2,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders